Previous close | 199.78 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 199.78 - 199.78 |
52-week range | 199.78 - 236.21 |
Volume | |
Avg. volume | 13,116 |
Market cap | N/A |
Beta (5Y monthly) | 0.51 |
PE ratio (TTM) | 16.50 |
EPS (TTM) | 12.10 |
Earnings date | 01 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Smith & Nephew's estimated fair value is UK£15.04 based on 2 Stage Free Cash Flow to Equity Current share...
Key Insights Given the large stake in the stock by institutions, Smith & Nephew's stock price might be vulnerable to...
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding phenomenon occurs and allows for dissip